Tag: Chapter 18A
Quartet advises on TYK Medicines’ chapter 18A debut on HKEX
O’Melveny, JunHe, MoFo, and Jingtian & Gongcheng aided TYK Medicines' USD74.3M debut on HKEX, the largest IPO under HK's Chapter 18A
Five law firms advise on largest chapter 18A listing in Hong Kong
Five law firms advised on Chinese biotechnology company Laekna’s HKD791 million chapter 18A offering, which is the largest such IPO to date this year
Luzhu Biotechnology launches HKD341m IPO via chapter 18A
Luzhu Biotechnology debuted on the HKEX through chapter 18A, the first biotech company without any revenue or profits to be listed this year, raising USD43.45 million
LATEST ON LAW.ASIA
Bundled and binding
A 1,200-article code, five interlocking books, and one tighter leash on Chinese business. The clock to August 2026 is ticking
